持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/06/15 | 3,095 | 3,100 | 3,060 | 3,065 | -35 | -1.1% | 36,300 |
| 2022/06/14 | 3,095 | 3,135 | 3,095 | 3,100 | -35 | -1.1% | 39,800 |
| 2022/06/13 | 3,100 | 3,145 | 3,095 | 3,135 | -10 | -0.3% | 33,900 |
| 2022/06/10 | 3,160 | 3,185 | 3,140 | 3,145 | -60 | -1.9% | 49,700 |
| 2022/06/09 | 3,175 | 3,220 | 3,175 | 3,205 | ±0 | ±0% | 38,100 |
| 2022/06/08 | 3,190 | 3,220 | 3,175 | 3,205 | +75 | +2.4% | 55,100 |
| 2022/06/07 | 3,135 | 3,145 | 3,110 | 3,130 | -5 | -0.2% | 46,800 |
| 2022/06/06 | 3,110 | 3,145 | 3,110 | 3,135 | +30 | +1% | 40,400 |
| 2022/06/03 | 3,120 | 3,150 | 3,100 | 3,105 | -15 | -0.5% | 37,500 |
| 2022/06/02 | 3,170 | 3,170 | 3,095 | 3,120 | -20 | -0.6% | 63,900 |
| 2022/06/01 | 3,125 | 3,175 | 3,120 | 3,140 | +40 | +1.3% | 61,100 |
| 2022/05/31 | 3,115 | 3,125 | 3,050 | 3,100 | -15 | -0.5% | 187,300 |
| 2022/05/30 | 3,085 | 3,140 | 3,055 | 3,115 | +60 | +2% | 124,500 |
| 2022/05/27 | 3,070 | 3,075 | 3,025 | 3,055 | +5 | +0.2% | 67,800 |
| 2022/05/26 | 3,070 | 3,095 | 3,050 | 3,050 | -20 | -0.7% | 59,300 |
| 2022/05/25 | 3,085 | 3,115 | 3,055 | 3,070 | -20 | -0.6% | 48,000 |
| 2022/05/24 | 3,100 | 3,135 | 3,065 | 3,090 | -70 | -2.2% | 71,100 |
| 2022/05/23 | 3,140 | 3,170 | 3,100 | 3,160 | +55 | +1.8% | 62,900 |
| 2022/05/20 | 3,050 | 3,115 | 3,050 | 3,105 | +55 | +1.8% | 76,200 |
| 2022/05/19 | 3,130 | 3,130 | 3,030 | 3,050 | -105 | -3.3% | 84,100 |
| 2022/05/18 | 3,165 | 3,185 | 3,130 | 3,155 | -10 | -0.3% | 54,800 |
| 2022/05/17 | 3,220 | 3,285 | 3,160 | 3,165 | +5 | +0.2% | 72,900 |
| 2022/05/16 | 3,365 | 3,415 | 3,150 | 3,160 | -175 | -5.2% | 128,300 |
| 2022/05/13 | 3,465 | 3,495 | 3,305 | 3,335 | -200 | -5.7% | 108,900 |
| 2022/05/12 | 3,625 | 3,640 | 3,525 | 3,535 | -160 | -4.3% | 40,500 |
| 2022/05/11 | 3,685 | 3,715 | 3,640 | 3,695 | +10 | +0.3% | 40,800 |
| 2022/05/10 | 3,695 | 3,725 | 3,650 | 3,685 | +35 | +1% | 64,600 |
| 2022/05/09 | 3,765 | 3,765 | 3,650 | 3,650 | -75 | -2% | 41,000 |
| 2022/05/06 | 3,705 | 3,750 | 3,695 | 3,725 | +30 | +0.8% | 34,200 |
| 2022/05/02 | 3,655 | 3,710 | 3,655 | 3,695 | -5 | -0.1% | 35,400 |
| 2022/04/28 | 3,545 | 3,700 | 3,545 | 3,700 | +175 | +5% | 49,300 |
| 2022/04/27 | 3,530 | 3,570 | 3,500 | 3,525 | -55 | -1.5% | 102,500 |
| 2022/04/26 | 3,625 | 3,640 | 3,580 | 3,580 | -20 | -0.6% | 36,800 |
| 2022/04/25 | 3,575 | 3,615 | 3,560 | 3,600 | -30 | -0.8% | 25,400 |
| 2022/04/22 | 3,610 | 3,635 | 3,595 | 3,630 | -20 | -0.5% | 23,100 |
| 2022/04/21 | 3,645 | 3,680 | 3,640 | 3,650 | ±0 | ±0% | 27,700 |
| 2022/04/20 | 3,620 | 3,670 | 3,610 | 3,650 | +25 | +0.7% | 22,000 |
| 2022/04/19 | 3,660 | 3,660 | 3,605 | 3,625 | -10 | -0.3% | 17,400 |
| 2022/04/18 | 3,685 | 3,700 | 3,585 | 3,635 | -110 | -2.9% | 29,100 |
| 2022/04/15 | 3,720 | 3,760 | 3,720 | 3,745 | +30 | +0.8% | 48,000 |
| 2022/04/14 | 3,700 | 3,745 | 3,685 | 3,715 | -5 | -0.1% | 21,400 |
| 2022/04/13 | 3,640 | 3,730 | 3,630 | 3,720 | +80 | +2.2% | 45,900 |
| 2022/04/12 | 3,725 | 3,725 | 3,625 | 3,640 | -135 | -3.6% | 50,800 |
| 2022/04/11 | 3,685 | 3,775 | 3,685 | 3,775 | +90 | +2.4% | 35,300 |
| 2022/04/08 | 3,720 | 3,720 | 3,640 | 3,685 | -20 | -0.5% | 55,500 |
| 2022/04/07 | 3,690 | 3,705 | 3,630 | 3,705 | -15 | -0.4% | 33,600 |
| 2022/04/06 | 3,770 | 3,810 | 3,720 | 3,720 | -55 | -1.5% | 31,200 |
| 2022/04/05 | 3,780 | 3,800 | 3,745 | 3,775 | +5 | +0.1% | 34,900 |
| 2022/04/04 | 3,730 | 3,785 | 3,730 | 3,770 | +45 | +1.2% | 25,900 |
| 2022/04/01 | 3,710 | 3,755 | 3,690 | 3,725 | -10 | -0.3% | 38,200 |
601～
650
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
